Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  ErbB-2 inhibitor ARRY-380
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
ARRY-380 and Trastuzumab in Treating Brain Metastases in Patients with HER2-Positive Breast Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-198, NCI-2013-01827, ARRAY-380-104X, NCT01921335
Start Over